Table 3.

Autocrine IL-6 production and resistance of myeloma cells to spontaneous and dexamethasone-induced apoptosis

Myeloma cell clone/lineApoptotic cells (%)
SpontaneousWith dexamethasone
Without IL-6With IL-6Without IL-6With IL-6
MCC-1 25.8 9.4 45.9 13.2 
MCC-2 5.4 3.6 7.3 6.9 
MCC-3 8.6 5.8 14.7 10.3 
MCC-4 47.3 8.2 85.6 12.7 
MCC-5 7.3 5.4 13.1 15.9 
MCC-6 35.4 5.9 68.4 8.5 
U-266 15.4 6.7 58.6 4.7 
IM-9 4.1 3.9 4.5 5.1 
Myeloma cell clone/lineApoptotic cells (%)
SpontaneousWith dexamethasone
Without IL-6With IL-6Without IL-6With IL-6
MCC-1 25.8 9.4 45.9 13.2 
MCC-2 5.4 3.6 7.3 6.9 
MCC-3 8.6 5.8 14.7 10.3 
MCC-4 47.3 8.2 85.6 12.7 
MCC-5 7.3 5.4 13.1 15.9 
MCC-6 35.4 5.9 68.4 8.5 
U-266 15.4 6.7 58.6 4.7 
IM-9 4.1 3.9 4.5 5.1 
Close Modal

or Create an Account

Close Modal
Close Modal